Condition: Hypertension · Acute Severe Hypertension · Hypertensive Emergency · Sponsor: Kardigan, Inc.
The purpose of this study is to evaluate the blood pressure-lowering effect of tonlamarsen in adult participants who were recently hospitalized and concurrently experienced an episode of acute severe hypertension.
This description comes directly from the study's public registry record.
Kardigan Clinical Study Information Team · +1-877-310-5135 · clinicaltrials@kardigan.bio
Always discuss trial participation with your own doctor first.
| Western Nephrology and Metabolic Bone Disease, PC - Arvada | Arvada, Colorado, United States | Recruiting |
| Homestead Associates in Research | Homestead, Florida, United States | Recruiting |
| Progressive Medical Research | Port Orange, Florida, United States | Recruiting |
| Richmond University Medical Center (RUMC) | Staten Island, New York, United States | Recruiting |
| Research Innovations, LLC | Beavercreek, Ohio, United States | Recruiting |
| Chattanooga Research & Medicine CHARM | Chattanooga, Tennessee, United States | Recruiting |
| Laguna Clinical Research Associates | Laredo, Texas, United States | Recruiting |
| Baylor Scott and White Research Institute - Temple | Temple, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07511361